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Regulatory control of DNA end resection by Sae2
phosphorylation
Elda Cannavo1, Dominic Johnson2, Sara N. Andres3,8, Vera M. Kissling4, Julia K. Reinert 5,6, Valerie Garcia2,9,
Dorothy A. Erie7, Daniel Hess 5, Nicolas H. Thomä 5, Radoslav I. Enchev4, Matthias Peter 4,
R. Scott Williams3, Matt J. Neale2 & Petr Cejka1,4
DNA end resection plays a critical function in DNA double-strand break repair pathway
choice. Resected DNA ends are refractory to end-joining mechanisms and are instead
channeled to homology-directed repair. Using biochemical, genetic, and imaging methods, we
show that phosphorylation of Saccharomyces cerevisiae Sae2 controls its capacity to promote
the Mre11-Rad50-Xrs2 (MRX) nuclease to initiate resection of blocked DNA ends by at least
two distinct mechanisms. First, DNA damage and cell cycle-dependent phosphorylation leads
to Sae2 tetramerization. Second, and independently, phosphorylation of the conserved
C-terminal domain of Sae2 is a prerequisite for its physical interaction with Rad50, which is
also crucial to promote the MRX endonuclease. The lack of this interaction explains the
phenotype of rad50S mutants defective in the processing of Spo11-bound DNA ends during
meiotic recombination. Our results deﬁne how phosphorylation controls the initiation of DNA
end resection and therefore the choice between the key DNA double-strand break repair
mechanisms.
DOI: 10.1038/s41467-018-06417-5 OPEN
1 Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera italiana (USI), Bellinzona 6500, Switzerland. 2 Genome
Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RH, UK. 3 Genome Integrity and Structural Biology Laboratory,
National Institute of Environmental Health Sciences, Department of Health and Human Services, US National Institutes of Health, Research Triangle Park
27709-2233 NC, USA. 4Department of Biology, Institute of Biochemistry, Eidgenössische Technische Hochschule (ETH), Zürich 8093, Switzerland.
5 Friedrich Miescher Institute for Biomedical Research, Basel 4058, Switzerland. 6 University of Basel, Basel 4056, Switzerland. 7 Department of Chemistry,
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill 27514 NC, USA. 8Present address: Michael G. DeGroote Institute for
Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton L8S4L8 ON, Canada. 9Present address:
Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli Calmettes, Inserm UMR1068, CNRS UMR7258, Aix Marseille Université, Marseille
13009, France. These authors contributed equally: Elda Cannavo, Dominic Johnson. Correspondence and requests for materials should be addressed to
M.J.N. (email: m.neale@sussex.ac.uk) or to P.C. (email: petr.cejka@irb.usi.ch)
NATURE COMMUNICATIONS |  (2018) 9:4016 | DOI: 10.1038/s41467-018-06417-5 | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
DNA double-strand breaks (DSBs) in vegetative cells arisefrom cellular exposure to radiation or chemicals, byenzymatic cleavage, or as a result of collapsed DNA
replication forks. Cells possess two main mechanisms for DSB
repair, either template-independent and often mutagenic end-
joining pathways or largely accurate homology-directed recom-
binational repair1. The pathway choice must be carefully balanced
to optimally maintain genome integrity at the lowest cost to
mutagenesis. As the sister chromatid serves as a template for most
recombinational repair events in vegetative cells, it is crucial to
initiate recombination only during the S/G2 phase of the cell
cycle, when such a template is available1. Illegitimate recombi-
nation in the absence of the correct repair template may lead to
gross chromosomal rearrangements and promote cellular trans-
formation in high eukaryotes2.
The choice between end-joining and recombination-based
mechanisms is governed by DNA end resection, which involves a
selective degradation of the 5’-terminated DNA strand near a
DSB3. DNA end resection generally inhibits end-joining and
commits the DSB repair to homologous recombination. The
resulting 3’ overhangs are then coated by Rad51 to search for the
homologous sequence1. At the molecular level, the initiation of
end resection and hence recombination is regulated by phos-
phorylation of key resection factors4,5. This includes a cell cycle-
dependent phosphorylation of Saccharomyces cerevisiae Sae2 or
human CtIP by a cyclin-dependent protein kinase (CDK) at S267
of Sae2 or T847 of CtIP6,7. Indeed, the Sae2 S267E mutation
mimicking constitutive phosphorylation partially bypasses the
requirement for CDK in DSB resection6. Sae2/CtIP functions
integrate with those of the Mre11-Rad50-Xrs2 (MRX, S. cerevi-
siae) or MRE11-RAD50-NBS1 (MRN, human) nuclease complex,
but the nature of the interplay has remained elusive. Speciﬁcally,
how phosphorylation of Sae2 at S267 and other, less deﬁned, sites
regulates DNA end resection on a mechanistic level has not been
elucidated8–12.
In meiosis, the Spo11 transesterase introduces in a pro-
grammed manner hundreds of DSBs during the prophase of the
ﬁrst meiotic division13. Unlike in vegetative cells where DSBs are
generally detrimental and a threat to genome stability, meiotic
DSBs are exclusively repaired by recombination using the
homologous chromosome as a preferential template, which serves
the purpose to generate diversity1. The resection and resulting
recombinational repair of meiotic DSBs absolutely require Sae2
and MRX and their orthologs, because Spo11 remains covalently
bound to the break ends and needs to be removed by MRX and
Sae214–17. This stands in contrast to resection in yeast vegetative
cells, which can be partially MRX-Sae2 independent18,19. To this
point, Rad50 separation of function alleles (rad50S) have been
found, which prevent Spo11 removal in meiosis, but are less
defective in vegetative cells14,16,20–22. Resection of all human
DSBs, both in vegetative and meiotic cells, requires MRN and
CtIP23. The processing of yeast meiotic DSBs thus serves as a
model for events that require the Mre11/MRE11 nuclease.
We previously demonstrated that yeast Sae2 functions as a co-
factor of the Mre11 nuclease to initiate resection of protein-
bound DNA ends24. The MRX/N complex is a 3’→5’ exonuclease
that has the opposite polarity than that required for resection25.
We and our colleagues showed that, in the presence of protein
blocks located at or near DNA ends, which may include Ku,
replication protein A (RPA), nucleosomes, Spo11 in meiosis, and
possibly other yet unidentiﬁed factors26–28, the 3’→5’ exonuclease
of MRX/N is inhibited. Instead, Sae2/CtIP stimulates the endo-
nuclease of MRX/N to cleave preferentially the 5’-terminated
DNA strand at DSB sites24,29. Here, using a combination of
biochemical, genetic, and imaging tools, we deﬁne how phos-
phorylation regulates the capacity of Sae2 to initiate DNA end
resection of blocked DNA ends. We show that phosphorylation at
multiple sites promotes the formation of active Sae2 tetramers
and additionally regulates a physical interaction with the
Rad50 subunit of the MRX complex. These phosphorylation-
dependent transitions turn Sae2 into a remarkably efﬁcient acti-
vator of the Mre11 nuclease. Our results provide a mechanistic
basis for the regulatory control of DSB repair pathway choice by
Sae2 phosphorylation.
Results
Sae2 phosphorylation stimulates the MRX endonuclease.
Phosphorylated Sae2/CtIP promotes the endonuclease activity of
Mre11 within the MRX/N complex24,29. Here we modiﬁed the
Sae2 expression procedure by including phosphatase inhibitors in
the Spodoptera frugiperda 9 culture media and cell extracts. This
allowed us to obtain hyperphosphorylated recombinant Sae2
(Fig. 1a). The modiﬁed polypeptide exhibited electrophoretic
mobility shift that was abolished upon treatment with λ phos-
phatase (Fig. 1a), which was reminiscent of its phosphorylation-
dependent transitions observed in yeast cells extracts in vivo8–10.
In contrast to our weakly phosphorylated previous preparation
(denoted “Sae2” in Fig. 1, in blue)24, the strongly phosphorylated
Sae2 (hereafter denoted “pSae2,” labeled red in Fig. 1), was up to
~10-fold more capable of stimulating the endonuclease of MRX
using DNA substrates, where a single or both ends were blocked
with streptavidin, serving as a protein block (Fig. 1b–f). Treat-
ment of pSae2 with λ phosphatase dramatically reduced its
capacity to promote the MRX endonuclease (Fig. 1e, f, labeled
pSae2 λ in green). These ﬁndings allowed us to study the
phosphorylation-dependent control of DNA end resection by
pSae2 in a reconstituted system to deﬁne its underlying
mechanism.
Sae2 oligomerization is important for DNA end resection.
Hyperphosphorylated pSae2 had a lower DNA-binding afﬁnity
compared to the λ phosphatase-treated variant (Fig. 1g, Supple-
mentary Fig. 1a). Furthermore, phosphorylation of Sae2 did not
affect MRX’s capacity to bind free or blocked DNA ends (Sup-
plementary Fig. 1b–e). Therefore, the failure of non-
phosphorylated Sae2 to stimulate the nuclease of MRX does not
likely stem from a defect in DNA binding of Sae2 or the
MRX–Sae2 complex.
The oligomeric state of biologically active Sae2 has been
controversial8,30. To investigate the size distribution of our
recombinant Sae2/pSae2 variants, we ﬁrst employed size exclu-
sion chromatography. Hyperphosphorylated pSae2, i.e., expressed
with phosphatase inhibitors, eluted in an oligomeric state,
spanning a range of peaks corresponding to a calibrated
molecular weight of 400–600 kDa (Fig. 1h, Supplementary
Fig. 2a). In contrast, most of Sae2 expressed without phosphatase
inhibitors was present in a very large multimeric complex,
equivalent to a globular species of several MDa, with only a small
fraction being oligomeric, i.e., comparable to the size distribution
of pSae2 (Fig. 1h). Dephosphorylation of pSae2 with λ
phosphatase resulted in the formation of soluble multimers that
shifted the polypeptide complex into the void volume of the size
exclusion column (Fig. 1h, Supplementary Fig. 2a). The peak
between 18 and 19 ml corresponds to λ phosphatase and not
pSae2 (Fig. 1h). The capacity of pSae2 to stimulate MRX thus
corresponded to the proportion of the polypeptide being an
oligomer (Fig. 1f–h), suggesting that phosphorylation-dependent
size distribution alters Sae2 function in DNA end resection.
To corroborate these data, we visualized the multimeric and
oligomeric species by transmission electron microscopy (two-
dimensional (2D) TEM). Indeed, the hypophosphorylated Sae2
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(corresponding to the blue species in Fig. 1f–h) was present in
large multimeric complexes, while hyperphosphorylated pSae2
assemblies (corresponding to the red species in Fig. 1f–h),
although heterogeneous, appeared much smaller (Fig. 1i, j and
Supplementary Fig. 2b, c). As both size exclusion and 2D TEM
only revealed an approximate average volume and molecular
weight range, we used atomic force microscopy (AFM) to
estimate the average number of subunits present in the active
pSae2 complex in solution without DNA. Based on the estimate
of 17 Sae2 phosphorylation sites (see ref. 8 and below), the
molecular weight of monomeric pSae2 is ~53.7 kDa. The volume
analysis with AFM revealed a distribution of the pSae2 protomers
with a peak corresponding to ~218.2 kDa based on a standard
curve and thus a tetrameric form (Fig. 1k, l)31, in agreement with
results obtained with Schizosaccharomyces pombe Ctp1 and the
N-terminal domain of human CtIP32,33.
To further deﬁne the roles of pSae2 oligomerization on its
capacity to promote MRX activity, we performed mutational
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analysis. The deletion of 169 residues from the N-terminus of pSae2
abolished self-interaction and the pSae2 ΔN169 in gel ﬁltration
experiments migrated as a very small unit likely corresponding to a
monomer, irrespectively of its phosphorylation status (pSae2
ΔN169 and pSae2 ΔN169 λ, Fig. 2a). This stands in contrast to
pSae2 ΔC95, lacking 95 C-terminal residues, which eluted as very
large multimeric species with a broad distribution in size exclusion
chromatography (Supplementary Fig. 2d).
Fig. 1 Phosphorylation of Sae2 regulates its capacity to promote the Mre11 endonuclease as well as its size distribution. a Recombinant Sae2 was expressed
and puriﬁed either without (lane 2) or with (lane 3) phosphatase inhibitors (PIs). The phosphorylated pSae2 was mock-treated (lane 5) or treated with λ
phosphatase (lane 6). b Phosphorylated (pSae2) and λ phosphatase-treated Sae2 (pSae2 λ) were used in nuclease assays with MRX and a DNA substrate
with a single end blocked with streptavidin. Red triangles in the substrate cartoon indicate DNA cleavage positions. c–e Sae2 variant prepared without PIs
(c, Sae2), with PIs (d, pSae2), and with PIs and then treated with λ phosphatase (e, pSae2 λ) were used in nuclease assays with MRX and a DNA substrate
with both ends blocked with streptavidin. Red triangles in the substrate cartoon indicate DNA cleavage positions. f Quantitation of assays such as shown in
c–e. Error bars, SEM, n≥ 3. g DNA-binding analysis of pSae2 untreated or treated with λ phosphatase, using 100-bp-long dsDNA as a substrate.
Quantitation of experiments such as shown in Supplementary Fig. 1a. Error bars, SEM, n= 3. h Size exclusion chromatography analysis of Sae2 variants
prepared without PIs (Sae2, blue), with PIs (pSae2, red), and Sae2 prepared with PIs and then treated with λ phosphatase (pSae2 λ, green). The black
rectangle indicates the position of the λ phosphatase peak. i, j Representative transmission electron microscopic images of Sae2 prepared without (Sae2,
800 nM, i) and with PIs (pSae2, 800 nM, j). Scale bar indicates 100 nm. k Representative atomic force microscopic image of pSae2 (50 nM). Examples of
tetrameric proteins are circled. Scale bar indicates 100 nm. l Frequency distribution of pSae2 particle volumes based on experiments such as shown in
k. Mean volume was calculated from nonlinear Gaussian ﬁt (black curve). Error bars, SEM; 1543 particles were analyzed
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Fig. 2 Sae2 oligomerization is required to promote the MRX nuclease in vitro and in vivo. a Size exclusion chromatography proﬁle of the C-terminal domain
of pSae2 (pSae2 ΔN169, residues 170–345) prepared with phosphatase inhibitors and either mock-treated (pSae2 ΔN169, green) or dephosphorylated
with λ phosphatase (pSae2 ΔN169 λ, green dashed). The proﬁle of full-length pSae2 (same as in Fig. 1h) is shown for reference. b Representative nuclease
assays with pSae2 ΔN169 treated or not with λ phosphatase and MRX. c Quantitation of assays such as shown in b; error bars, SEM, n≥ 4. d Coomassie-
stained polyacrylamide gel showing pSae2 ΔN169 treated or not with λ phosphatase. e A scheme of the Spo11-oligonucleotide assay. See text for details.
f Spo11-oligonucleotide assay performed with wt SAE2 (left), sae2Δ (middle), or wt SAE2 expressed from a centromeric plasmid under the control of its
natural promoter and terminator (right). The red triangles mark the long and short Spo11-oligonucleotide species generated in wild-type cells. The open
bracket marks MRX-Sae2-independent “double-cut” Spo11-oligonucleotide species observed in wild type and sae2Δ (D.J., V.G., and M.J.N, manuscript in
preparation). The black triangle marks a non-speciﬁc terminal deoxynucleotidyl transferase band. g–h Spo11-oligonucleotide assay as in f, performed in
sae2Δ cells with wt SAE2 or N-terminal truncations expressed from an inducible promoter 4 h after the onset of meiosis. Samples from uninduced cells are
labeled in black; samples from cells induced with β-estradiol are labeled in red. The numbers below represent the amount of Spo11-oligonucleotides relative
to wild type
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The phosphorylated pSae2 ΔN169 fragment was ~3-fold less
capable to promote the endonuclease of MRX compared to wild-
type (wt) pSae2 (Fig. 2b, c), although still showing a
phosphorylation-dependent electrophoretic mobility shift
(Fig. 2d). Importantly, the residual stimulatory capacity of the
monomeric pSae2 ΔN169 fragment was still dependent on its
phosphorylation, as its treatment with λ phosphatase resulted in
an almost complete loss of activity (Fig. 2b, c). Similar results
were obtained with the pSae2 L25P E171G mutant, correspond-
ing to the sae2–58 allele deﬁcient in self-interaction and impaired
cellular functions30. This pSae2 L25P E171G variant appeared
much smaller than wild type in gel ﬁltration and had a decreased
capacity to promote MRX, but its residual activity was also still
dependent on its phosphorylation (Supplementary Fig. 2e–i).
Therefore, phosphorylation controls Sae2 function in resection on
at least two levels. First, it regulates higher-order pSae2
oligomerization and the redistribution to active pSae2 oligomers
from multimeric forms (>4N). Second, additionally and inde-
pendently, phosphorylation regulates the capacity of pSae2 to
promote MRX by another mechanism, which will be revealed
below. This is evident from experiments showing that phosphor-
ylation also promotes the resection capacity of monomeric pSae2
variants.
Sae2 truncations promote resection of meiotic DSBs. To deﬁne
the function of Sae2 in the resection of blocked DNA ends
in vivo, we used the Spo11-oligonucleotide formation assay14,34.
Most phenotypes associated with sae2 defects in vivo reﬂect its
pleiotropic functions, including indirect regulation of checkpoint
signaling associated with altered persistence of MRX and Rad9
bound to DNA ends35–37. Instead, the Spo11-oligonucleotide
assay is a direct readout of the resection capacity of MRX-Sae2
in vivo. The assay scores the release of covalent Spo11-DNA
fragments from meiotic DSB ends (Fig. 2e). It has been estab-
lished previously that this requires both MRX and Sae214,38.
MRX-Sae2 cleave DNA adjacent to the Spo11 complex near DSBs
or at locations further away38. In the latter case, the initial
endonucleolytic cleavage is followed by exonucleolytic degrada-
tion by the 3’→5’ MRX exonuclease toward the DNA end38. Cells
from various stages of the meiotic prophase were lysed, and
FLAG-tagged Spo11-oligonucleotide complexes were enriched by
immunoprecipitation. The ssDNA component was labeled at the
3’ end by terminal deoxynucleotide transferase and [α-32P]dCTP
(Fig. 2e)34. As established previously, two major SAE2-dependent
products can be observed14. The deﬁciency in the Spo11-
oligonucleotide formation in sae2Δ mutants can be com-
plemented by SAE2 expressed from a plasmid (Fig. 2f, g). We
used either a centromeric vector (pVG25 CEN:SAE2), where
SAE2 expression was driven by its cognate promoter (Fig. 2f), or
from a genomic β-estradiol-inducible promoter (PGAL1:SAE2)
that leads to higher levels of SAE2 expression and generally
results in a better efﬁciency of complementation (Fig. 2g). In
accord with our reconstituted reactions, various truncations of
the N-terminal domain of Sae2 resulted in a decrease but not a
complete elimination of the Spo11-oligonucleotide signal in
experiments where the Sae2 truncations were overexpressed
(Fig. 2h). The self-interaction impaired Sae2 L25P mutation
resulted in a complete deﬁciency in resection of Spo11-bound
DSBs, even when the Sae2 mutant was overexpressed (Supple-
mentary Fig. 3a, b). This showed that the L25P mutation also
in vivo brings about end-processing defect that is comparable to a
complete elimination of the entire 170 residues long N-terminal
domain. These results collectively suggest that proper Sae2 oli-
gomerization is required for its optimal capacity to promote
resection of meiotic DSBs in conjunction with MRX in vivo.
Sae2 phosphorylation by CDK is not sufﬁcient for resection.
CDK-dependent phosphorylation of Sae2 at the CDK consensus
site of S267 is known to be critical for its function in DNA end
resection and homologous recombination6, but the mechanism of
how phosphorylation regulates Sae2 function has not been
deﬁned. In accord with previous work6,24, we show that the non-
phosphorylatable alanine substitution of S267 dramatically
reduced the capacity of pSae2 to promote the MRX endonuclease
(Fig. 3a, b). This stands in contrast to the other two CDK con-
sensus sites in pSae2, S134, and S179, which had no effect on
pSae2 activity when mutated to alanine (Fig. 3a, b). In contrast,
the phosphomimetic glutamic acid substitution mutant (pSae2
S267E) supported resection, and its activity was partially resistant
to treatment with λ phosphatase (Fig. 3c–e)6. The ~5-fold
decrease in MRX-dependent DNA cleavage upon depho-
sphorylation of pSae2 S267E demonstrated that other sites in
pSae2, in addition to S267, must be phosphorylated for its opti-
mal stimulation of the MRX endonuclease. Accordingly, the
activity of the phosphomimetic double mutants pSae2 S134E
S267E and pSae2 S179E S267E mutants were ~1.5-fold more
resistant to λ phosphatase treatment than pSae2 S267E alone
(Supplementary Fig. 4a–c), suggesting that the other two putative
CDK sites may play a supporting function. However, the capacity
of all phosphomimetic CDK site variants to stimulate MRX
decreased upon λ phosphatase treatment, showing that other
non-CDK sites must also be involved.
Furthermore, we show that pSae2 that had been depho-
sphorylated by λ phosphatase can be subsequently partially
activated upon phosphorylation by human recombinant CDK1/
Cyclin B in vitro (Fig. 3f, g). This suggests that the size
distribution transitions of pSae2 are likely dynamic, and active
pSae2 may be obtained not only by de novo protein synthesis but
also upon phosphorylation of the soluble multimer pool of Sae28.
In accord with the observations in vitro, the sae2 S267A cells
were deﬁcient in the Spo11-oligonucleotide formation assay, even
when Sae2 S267A was overexpressed (Fig. 3h, Supplementary
Fig. 4d, e). In contrast, sae2 S267E cells supported resection of
meiotic Spo11-bound DSBs, albeit to a lesser degree than wt
(Fig. 3h, Supplementary Fig. 4d). Resection of meiotic DSBs was
not largely affected by substitutions in S134 and S179 of pSae2
(Fig. 3h), similar to the in vitro experiments (Fig. 3a, b).
To deﬁne how phosphorylation of pSae2 at S267 promotes its
function in resection, we analyzed the size distribution of
recombinant pSae2 S267E and pSae2 S267A. Both pSae2 variants
showed a comparable phosphorylation-dependent shift in electro-
phoretic mobility in polyacrylamide gels (Fig. 3e) and eluted in the
oligomeric fraction during gel ﬁltration just like wt pSae2
(Supplementary Fig. 4f, g). Furthermore, the S267E mutation
did not prevent the pSae2 variant from multimerizing upon
dephosphorylation with λ phosphatase (Supplementary Fig. 4g).
This suggested that phosphorylation of pSae2 at the CDK site of
S267 regulates pSae2 by a mechanism that is distinct from any
effects on oligomerization. To conﬁrm this, we next analyzed the
effect of the S267 substitution mutations in the monomeric
C-terminal fragment of pSae2. We observed that the S267A
substitution largely eliminated the residual capacity of the
pSae2 ΔN169 to promote MRX endonuclease activity on
protein-blocked ends (Supplementary Fig. 4h, i), while the
S267E mutation had a smaller effect (Supplementary Fig. 4j, k).
We note that the S267E substitution had no apparent effect on the
function of the full-length pSae2 polypeptide (Fig. 3c, d), but
reduced the resection capacity of the C-terminal fragment in
conjunction with MRX at least three-fold (Supplementary Fig. 4j,
k), reminiscent of the reduction of the resection capacity caused by
the S267E mutation in vivo (Fig. 3h). Notably, λ phosphatase
treatment of the pSae2 ΔN169 S267E mutant marginally reduced
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its function to promote MRX; this decrease, however, remained
statistically signiﬁcant (Supplementary Fig. 4j, k). Together, these
results demonstrate that CDK-dependent phosphorylation of
Sae2 at S267 is critical but not sufﬁcient to maximally promote
DNA end resection by MRX and that this occurs by a mechanism
that is distinct from the regulation of Sae2 oligomerization.
Sae2 phosphorylation by Mec1/Tel1 has little role in resection.
Single or combined mutations in the putative Mec1 or Tel1 sites at
SQ/TQ motifs at positions S73, T90, S249, and T279 of pSae2 did
not affect its capacity to regulate the MRX nuclease in vitro
(Fig. 4a–f, Supplementary Fig. 5a). Likewise, the quintuple pSae2
S73E T90E S249E T279E S267E mutant was no more active than
pSae2 S267E upon dephosphorylation with λ phosphatase
(Fig. 4c–e, see also Supplementary Fig. 5b–e), although the four
phosphomimetic amino acid substitutions slightly prevented
pSae2 multimerization upon dephosphorylation (Supplementary
Fig. 5f, g). As above, the effects of the sae2 mutations were more
pronounced in vivo. Single non-phosphorylatable substitutions of
S73A and T279A brought about defects in Spo11 release that were
more severe than respective phosphomimetic mutations, while
T90 was sensitive to both substitutions and S249 was not impor-
tant (Fig. 4g, h). However, the non-phosphorylatable T279A
substitution (together with S278A) was able to complement sae2Δ
when overexpressed, indicating that phosphorylation of these sites
is not absolutely essential to regulate Sae2 (Fig. 4i) but likely
plays a supporting function. Nevertheless, both Mec1- and
Tel1-dependent modiﬁcations promote the release of Spo11-oli-
gonucleotides, as tel1Δ or mec1 cells show a reduction in the
Spo11-oligonucleotide signal, while simultaneousMEC1 and TEL1
deﬁciency almost completely eliminated meiotic DSB processing
(Supplementary Fig. 5h), in agreement with previous results39.
While most phosphorylation sites in pSae2 promote its
function in resection, one notable exception is the SQ site at
S289. While the non-phosphorylatable substitution S289A had no
effect in the Spo11-oligonucleotide assay, phosphomimicking
sae2 S289D or S289E variants were completely defective (Fig. 4j).
The same effects were observed with the respective recombinant
protein variants in vitro in conjunction with MRX (Fig. 4k, l). The
S289E mutation was inhibitory also in combination with the
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Fig. 3 CDK phosphorylation of Sae2 is prerequisite, but not sufﬁcient, to promote the MRX nuclease. a Nuclease assays with MRX and pSae2 variants
mutated in one of the three CDK consensus sites (S267, S134, and S179) into alanine. All mutants were expressed in the presence of phosphatase
inhibitors. Substrate used was the same as in Fig. 1c. b Quantitation of the assays such as shown in a; error bars, SEM; n≥ 3. c Nuclease assays with pSae2
S267E phosphomimicking variant, expressed in the presence of phosphatase inhibitors. The pSae2 S267E protein was mock or λ phosphatase treated, as
indicated. d Quantitation of assays such as shown in c; error bars, SEM; n≥ 3. e Representative polyacrylamide gel (4–15%) electrophoretic analysis of the
indicated pSae2 variants, treated or not with λ phosphatase, stained with Coomassie brilliant blue. f Sae2 was expressed and dephosphorylated with λ
phosphatase during puriﬁcation (Sae2 λ). The polypeptide was then mock-treated or phosphorylated with recombinant CDK1/Cyclin B, where indicated,
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phosphomimetic CDK site S267E mutant (Fig. 4m), and this
modiﬁcation might thus represent a negative regulatory signal to
turn off the MRX-Sae2 nuclease. Alternatively, the E/D substitu-
tions may cause protein misfolding, and it therefore remains to be
established whether S289 phosphorylation occurs as a regulatory
mechanism in cells.
In addition to promoting the Mre11 nuclease, Sae2 was reported
to possess an intrinsic nuclease activity, and the Sae2 mutant
(N123A R127A) abolished this function40. However, we found the
sae2 N123A R127A mutant behaved as wild type in the Spo11-
oligonucleotide formation assay (Supplementary Fig. 5i). We
therefore conclude that Sae2 functions in resection as an activator
of Mre11, rather than having an intrinsic catalytic function24.
Multiple phosphorylations regulate Sae2 role in resection.
Dephosphorylation of all pSae2 phosphomimetic substitution
mutants and their combinations analyzed to this point reduced
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the capacity of Sae2 to promote the MRX nuclease and resulted in
increased electrophoretic mobility. This indicated that additional
residues in our recombinant pSae2 are phosphorylated and
facilitate pSae2 function to promote MRX. To deﬁne these
phosphorylation sites, we subjected our recombinant protein to
mass spectrometry and identiﬁed multiple sites that are likely
to be modiﬁed (Supplementary Fig. 6a, b). Notably, many of
these sites overlapped with positions identiﬁed in previous
studies8,12,41. However, as our protein was expressed in insect
cells, we cannot exclude that some of the non-overlapping sites
are not modiﬁed in yeast or are rapidly dephosphorylated in cells.
We observed that seven non-phosphorylatable alanine sub-
stitutions in the pSae2 N-terminus had no effect on its activity,
while six alanine substitutions in the C-terminal region of the
full-length polypeptide completely eliminated its stimulatory
effect on MRX (Supplementary Fig. 6c–e). This showed that
phosphorylation of pSae2 at its C-terminal rather than the N-
terminal part is more important for its function in resection.
For subsequent analysis, we selected 22 putative pSae2
phosphorylation sites based on our mass spectrometric analysis
and previous work; 15 of those pSae2 sites had been previously
found to be modiﬁed (Fig. 5a)8,12,41. Thirteen of these sites were
identiﬁed in Flag-Sae2 pulldown from yeast cells8 and thus very
likely to be modiﬁed in vivo. We next expressed and puriﬁed
three full-length phosphomimetic pSae2 variants in the presence
of phosphatase inhibitors, with the respective substitution
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mutations in the N- or C-terminal parts of the full-length
polypeptide (pSae2 12NE or pSae2 10CE, respectively) or with all
22 mutations combined (pSae2 22E) (Fig. 5a). We observed that
the 12 N-terminal pSae2 substitutions failed to render the pSae2
variant activity resistant to dephosphorylation (Fig. 5b–f).
Furthermore, the λ phosphatase-treated pSae2 12NE multi-
merizes, as revealed by size exclusion chromatography (Fig. 5g,
Supplementary Fig. 6f). In contrast, the phosphomimetic pSae2
10CE mutant retained partial activity upon dephosphorylation
and did not multimerize (Fig. 5c, e–g, Supplementary Fig. 6f),
underscoring the importance of C-terminal pSae2 phosphoryla-
tion in regulating activity and dephosphorylation. Nevertheless,
even for the pSae2 10CE mutant, a reduced capacity to stimulate
MRX following 10CE dephosphorylation indicated that addi-
tional phosphorylation events promote maximal activity
(Fig. 5c–e). Consistent with this hypothesis, λ phosphatase
treatment shifted pSae2 10CE in a polyacrylamide gel (Fig. 5f).
Finally, we analyzed the pSae2 22E variant, which possessed all
22 phosphomimetic substitution mutations. Strikingly, the pSae2
22E variant did not change its mobility in a polyacrylamide gel
upon λ phosphatase treatment (Fig. 5f). The pSae2 22E mutant
was still able to promote MRX, although ~10-fold less efﬁciently
that wt pSae2, but the capacity of the pSae2 22E variant to
stimulate MRX was not sensitive to λ phosphatase (Fig. 5d, e).
Also, the pSae2 22E protein did not multimerize upon λ
phosphatase treatment (Fig. 5g, Supplementary Fig. 6f), showing
that our analysis identiﬁed all residues that were important for
pSae2 function. We conclude that a number of residues both in
the N- and C-terminal parts of pSae2 must be phosphorylated for
its maximal stimulatory effect on the MRX nuclease. Phosphor-
ylation sites in the C-terminal part of pSae2 are more important
than those in the N-terminal region.
Phosphorylated C-terminus of Sae2 interacts with Rad50. To
deﬁne oligomerization-independent functions of Sae2 phos-
phorylation, we set out to test whether phosphorylation regulates
a direct physical interaction between Sae2/pSae2 and the MRX
complex. The interaction between MRX and Sae2 is rather weak.
Using recombinant proteins, we previously found that Sae2
could interact with the Mre11 and Xrs2 subunits but failed to
detect an interaction with Rad5024. To determine whether
hyperphosphorylation of Sae2 affects its interaction with
MRX, we immobilized recombinant phosphorylated or non-
phosphorylated maltose-binding protein (MBP)-tagged Sae2 on
amylose resin and tested for their interaction with the MRX
complex. As shown in Fig. 6a, the MRX complex interacted with
Sae2 irrespectively of Sae2 phosphorylation.
As MRX and Sae2 interact via multiple interfaces24, we next set
out to test the interaction between the C-terminal pSae2 domain
(pSae2 ΔN169), i.e., the minimal unit that is required to promote
MRX activity, with individual subunits of the MRX complex. Xrs2
is not essential for the MRX-Sae2 endonuclease42, so we tested for
interactions with Mre11 and Rad50. Unlike full-length Sae224, we
found that the C-terminal fragment did not interact with Mre11
(Supplementary Fig. 7). To test for interaction with Rad50, we
expressed and puriﬁed FLAG-tagged Rad50 and immobilized it
on anti-FLAG afﬁnity resin. The resin was then incubated with
phosphorylated (mock-treated) or λ phosphatase-treated pSae2
ΔN169 (Fig. 6b). Strikingly, we observed that the C-terminus of
Sae2 could interact with Rad50 only in its phosphorylated state.
The same results were obtained when the experiment was
performed reciprocally, i.e., when his-tagged pSae2 ΔN169 was
immobilized on NiNTA resin and then incubated with Rad50.
Also in this case, the C-terminus of Sae2 interacted with Rad50
only in its phosphorylated state (Fig. 6c). Importantly, the
phosphorylation-dependent interaction between the pSae2
ΔN169 and Rad50 was not affected by the Rad50 K40A mutation,
which prevents ATP binding and renders the MRX nuclease
refractory to stimulation by pSae2 (Fig. 6c)24.
In 1990, Kleckner and colleagues isolated a group of rad50
separation of function mutants (rad50S) that blocked spore
formation in meiosis but exhibited less severe sensitivity to the
methylating agent methyl methane sulfonate compared to a
rad50Δ strain15. Later, it was shown that the rad50S cells are
impaired in the processing of DNA ends blocked by proteins
including topoisomerases and Spo1114,16,20–22, and the corre-
sponding M-Rad50S-X variant (containing Rad50 K81I mutant,
representative of Rad50S) was deﬁcient in DNA clipping in
conjunction with Sae2 in vitro24. The Rad50 K81I mutation lies in
a surface patch, and it is not expected to be deﬁcient in ATP
hydrolysis but rather was proposed to affect a protein–protein
interaction43. In fact, Sae2 overexpression could partially suppress
single-strand annealing defects of rad50S cells, suggesting that the
MRX-Sae2 interaction may be affected39. Strikingly, we observed
that recombinant Rad50S was impaired in its interaction with the
C-terminal part of Sae2, even when it was phosphorylated
(Fig. 6d). Therefore, we conclude that the Rad50S mutant is
deﬁcient in the physical interaction with phosphorylated Sae2,
which explains why the M-Rad50S-X complex is refractory to
regulation by pSae224, and therefore defective in meiosis14,16.
Together, our results demonstrate that, while phosphorylation of
Sae2 does not affect its overall capacity to interact with MRX, it
controls the speciﬁc physical and functional interaction with the
MRX subunit Rad50, which is a prerequisite for the regulation of
the Mre11 nuclease.
Discussion
DNA end resection commits the repair of broken DNA to the
recombination pathway3. To prevent unscheduled DNA degra-
dation and aberrant recombination, the initiation of DNA end
resection must be under a tight control. It has been established
that phosphorylation of Sae2/CtIP is a key component of this
control mechanism6. However, how phosphorylation promotes
Sae2 function to stimulate DNA end resection has remained
elusive. We show that phosphorylation reduces the capacity of
pSae2 to bind DNA, which may be due to conformational change
or a negative overall charge of the hyperphosphorylated poly-
peptide. We also cannot exclude that non-phosphorylated or
weakly phosphorylated Sae2 aggregates on DNA, which increases
its apparent DNA-binding activity. However, as DNA cleavage
positions are solely determined by the MRX complex and Sae2
only promotes cleavage efﬁcacy, we favor the hypothesis that
DNA binding by Sae2, at least in the simple reconstituted system,
is not required for the clipping function of MRX.
Here we report that extensive phosphorylation of Sae2 controls
its capacity to promote the MRX nuclease by at least two distinct
mechanisms (Fig. 7). During the G1 phase of the cell cycle, Sae2
exists in an unphosphorylated state and is part of an inactive
soluble multimeric complex8. During S phase in mitotic cells and
the prophase of the ﬁrst meiotic division, as well as upon DNA
damage6,10, Sae2 is extensively phosphorylated resulting in an
electrophoretic mobility shift8,11. First, we show that phos-
phorylated pSae2 transitions toward smaller molecular weight
complexes. Our AFM analysis shows that phosphorylation pro-
motes the formation of pSae2 tetramers in solution without DNA,
which likely represent the active pSae2 species that optimally
promote the Mre11 nuclease within the MRX complex. MRX
then initiates DNA end resection, which is especially important
for the processing of protein-bound DNA ends. Our results are in
agreement with previous observations that Sae2 oligomerization
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is critical for its activity30 and observations with Sae2 orthologs in
S. pombe and humans32,33.
Second, we also show that additionally and independently of
regulating size distribution, phosphorylation of the C-terminal
region of Sae2 is necessary for a direct physical interaction with
the Rad50 subunit of MRX. Sae2 interacts with all components of
the MRX complex including Mre11 and Xrs224, but the
phosphorylation-dependent interaction with Rad50 is particularly
important for DNA end resection. ATP hydrolysis by Rad50 is
necessary for the MRX-Sae2 endonuclease24. Because phos-
phorylated Sae2 also promotes the exonuclease of Mre11 when
ATP hydrolysis is allowed (Cannavo et al., manuscript in pre-
paration), we suggest that phosphorylated Sae2 controls the
Mre11 nuclease by promoting productive ATP hydrolysis by
Rad50. The direct physical interaction between Sae2 and Rad50
thus likely mediates this process—an idea that is supported by our
observation that the phosphorylation-dependent interaction
between Sae2 and Rad50 is abolished by the rad50S mutation.
These observations also explain why the M-Rad50S-X complex
fails to process meiotic Spo11-bound DSBs in vivo14,16 and is
refractory to stimulation by phosphorylated Sae2 in vitro24.
We deﬁne the function of the individual phosphorylation sites
in Sae2 found by mass spectrometric analysis and in previous
studies. Although we found 22 sites that are likely to be modiﬁed
in the population of recombinant pSae2, most individual poly-
peptides will contain only a fraction of those modiﬁcations
(Supplementary Fig. 6b). We observed that, while Sae2 mutations
had a more pronounced effect in the Spo11-oligonucleotide assay
in vivo than in the reconstituted biochemical assays, there was
generally a good correlation between both approaches. Phos-
phorylation of the conserved CDK site of Sae2 at S267 is critical
for its resection function in vitro and in vivo6, but there is a need
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Fig. 6 Phosphorylated C-terminus of Sae2 interacts with Rad50. a Full-length phosphorylated recombinant MBP-tagged pSae2 was mock-treated or
dephosphorylated with λ phosphatase upon binding to amylose resin and incubated with recombinant MRX complex. The eluates were visualized by silver
staining. Prescission protease was added to all samples as a protein stabilizer and to cleave the MBP tag off pSae2. b The FLAG-tagged recombinant Rad50
protein was immobilized on anti-FLAG afﬁnity resin and incubated with phosphorylated C-terminal domain of pSae2 (pSae2 ΔN169, residues 170–345),
which had been either mock-treated or dephosphorylated with λ phosphatase. The bound proteins were eluted and detected by Ponceau staining or
western blotting. Avidin was added to elution buffer and shows equal loading. c The phosphorylated recombinant MBP-tagged C-terminal domain of pSae2
(residues 170–345) was bound to amylose resin, eluted, cleaved with prescission protease, and immobilized on NiNTA resin. The bound pSae2 ΔN169 was
mock-treated or dephosphorylated with λ phosphatase and incubated with recombinant wild-type Rad50 or ATP binding-deﬁcient Rad50 K40A. Proteins
were eluted and visualized by Ponceau staining or western blotting. Avidin was added to elution buffer and shows equal loading. d Assay as in
c. Phosphorylated C-terminal domain of pSae2 was incubated with wild-type Rad50 or Rad50 K81I (representative Rad50S) mutant
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for the modiﬁcation of a number of additional sites that play a
supporting role. This may include other CDK sites, Mec1/
Tel1 sites, or other kinases such as Cdc5 or the Dbf4-depenent
kinase, whose function in Sae2 regulation has, however, not yet
been deﬁned. Although phosphorylation of sites in the C-terminal
part of Sae2 is more important, multiple residues both in the N
and C-terminal domains of Sae2 must be modiﬁed for optimal
activity. We propose that these additional sites need to alter the
charge of the Sae2 polypeptide, which then affects its size dis-
tribution, rather than playing a sequence-speciﬁc function.
Collectively, our results support the view that the primary
function of Sae2 in DSB resection and meiosis is mediated by the
stimulation of the Mre11 nuclease24 and not an intrinsic catalytic
function of Sae240. In accord, the phosphorylation-dependent
regulatory control of DNA end resection utilizes Sae2 as an
activator of MRX. In the absence of a pro-resection phosphor-
ylation signal, the Mre11 nuclease activity is restricted. Once
activated upon Sae2 phosphorylation, Mre11 initiates resection,
which commits DSB repair to the recombination pathway
(Fig. 7). Our results will be relevant for understanding the reg-
ulation of DNA end resection in human cells. Whereas the
Xrs2 subunit of MRX is dispensable for resection in S. cerevisiae
as long as nuclear import of Mre11-Rad50 is guaranteed42, NBS1
is in contrast essential for resection in humans28,29. This likely
reﬂects more complex control mechanisms in high eukaryotes;
however, basic elements of the resection process are well con-
served between yeast and humans. The analysis reported here will
thus be invaluable to understand how phosphorylation controls
the interplay of MRN and CtIP, defects in which are linked to
multiple human pathologies.
Methods
Preparation of recombinant proteins. The S. cerevisiae Mre11-Rad50-Xrs2
complex contained a His-tag and a FLAG-tag at the C-termini of Mre11 and Xrs2,
respectively. MRX was expressed in Sf9 cells and puriﬁed using afﬁnity chroma-
tography44. Recombinant pSae2, containing a MBP tag at the N-terminus and a
His-tag at C-terminus, was expressed in Sf9 cells and puriﬁed by sequential afﬁnity
chromatography steps using amylose resin (New England Biolabs), followed by the
cleavage of the MBP tag with PreScission protease (12 μg of protease per 100 μg
MBP–Sae2–His). Finally, pSae2 was puriﬁed using NiNTA agarose (Qiagen). We
modiﬁed our original procedure24 to preserve maximal phosphorylation of the
protein. Speciﬁcally, Okadaic acid (100 nM, Calbiochem) was added to the Sf9 cells
for the last 3 h of culture before harvesting. The lysis buffer was supplemented with
the following phosphatase inhibitors: okadaic acid (100 nM), sodium orthovana-
date (1 mM, Sigma), sodium ﬂuoride (20 mM, Sigma), and sodium pyrophosphate
(15 mM, Applichem). Where indicated, pSae2 was dephosphorylated with λ
phosphatase (New England Biolabs). To this point, 1.3 μg of pSae2 was incubated
at 30 °C for 15 min with 280 U of λ phosphatase (New England Biolabs) in the
manufacturer’s recommended buffer in a volume of 20 μl (ﬁnal pSae2 concentra-
tion 1.6 μM). As a control, mock-treated pSae2, incubated in the λ phosphatase
reaction buffer, but without λ phosphatase, was used. The Sae2 variants were then
returned on ice and immediately added to the nuclease reaction mixture. We note
that pSae2 did not lose its capacity to promote MRX during mock treatments
(compare Fig. 1d with Supplementary Fig. 2g). The Sae2 variant that has been
obtained upon dephosphorylation of the originally phosphorylated pSae2 is
denoted as “pSae2 λ”. Alternatively, to obtain non-phosphorylated Sae2 already
during protein puriﬁcation, phosphatase inhibitors were omitted from the cell
culture medium and the lysis buffer. In addition, manganese chloride (1 mM) and λ
phosphatase (New England Biolabs, 20,000 units for puriﬁcation from 1.6 l Sf9 cell
culture) were added to MBP-Sae2 after elution from amylose resin, before the
addition of Prescission protease. Incubation was carried out ﬁrst at 30 °C for
30 min and then at 4 °C for 90 min. This Sae2 species is denoted as “Sae2 λ”.
To phosphorylate Sae2 in vitro, Sae2 λ was incubated with 15 U of recombinant
human CDK1/cyclin B (New England Biolabs) for 30 min at 30 °C and added to the
nuclease reaction mixture. The various Sae2 mutants were obtained by mutagenesis
of the SAE2 gene in the pFB-MBP-Sae2-his plasmid using the QuikChange II XL
Site-directed Mutagenesis Kit (Agilent) according to the manufacturer’s recom-
mendations. Multiple mutant combinations were obtained upon gene synthesis
(GenScript). All Sae2 variants were then expressed in Sf9 cells and puriﬁed as
described above, with the whole procedure scaled down proportionally. The yield
of pSae2 mutants, prepared from 250 ml cell culture volume, was ~ 400–800 μg.
Recombinant wt Rad50-Flag, K40A, and K81I (Rad50S) variants were expressed
in Sf9 cells using pFB-Rad50-FLAG vectors and derivatives. Soluble extracts from
800 ml cells were obtained as for Sae224 but with a lysis buffer lacking
ethylenediaminetetraacetic acid (EDTA) and containing only 0.5 mM β-
mercaptoethanol to avoid reduction of the anti-FLAG antibody. Soluble extracts
were incubated with 0.6 ml of anti-FLAG M2 afﬁnity gel (Sigma, A2220) for 1 h at
4 °C. First, the resin was extensively washed with ~150 ml of “High salt” wash
buffer containing 50 mM Tris-HCl pH 7.5, 0.5 mM β-mercaptoethanol, 300 mM
NaCl, 0.5 mM phenylmethylsulfonyl ﬂuoride, 10% (v/v) glycerol, and 0.1% (v/v)
NP40. The resin was then additionally washed with ~50 ml of “Low salt” wash
buffer (same as “High salt” buffer, but without NP40 and with only 150 mM NaCl).
The proteins were eluted with “Low salt” wash buffer supplemented with 200 μg/ml
of 3X FLAG peptide (Sigma).
DNA substrates. The 50 and 70 bp DNA substrates were labeled at the 3’ end with
terminal deoxynucleotidyl transferase (New England Biolabs) and [α-32P]-cordy-
cepin 5’-triphosphate (Perkin Elmer)24. The oligonucleotides used for the 100 bp
dsDNA were labeled identically and included Bio100 (GTAAGTGCCGC
GGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCCAC
CTCA TAATCTTCTGCCATGGTCGTAGCAGCCTCCTGCATC) and Bio100c
(GATGCAGGAGGCTGCTACGACCATGGCAGAAGATTATGAGGTGGAGTA
CGCGCCCGGGGAGCCCAAGGGCACGCCCTGGCACCCGCACCGCGGCAC
TTAC). T in bold indicates the position of the internal biotin label.
Electrophoretic mobility shift assay. The electrophoretic mobility shift assay to
determine the DNA-binding capacity of Sae2/pSae2 and the MRX complex was
carried out with a 15 μl total reaction volume in a binding buffer containing 25 mM
Tris-acetate, pH 7.5, 1 mM dithiothreitol, 2 mM magnesium acetate, 0.1 mg/ml
bovine serum albumin (New England Biolabs), and 1 nM (in molecules) DNA
substrates. In reactions where MRX was present, 1 mM ATP was added to the
buffer. Where indicated, streptavidin (Sigma, 30 nM) was added to the mixture and
preincubated for 5 min at room temperature. Puriﬁed proteins were then added on
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Fig. 7 The function of Sae2 phosphorylation in the control of DNA end
resection. Phosphorylation allows the formation of a tetrameric Sae2 form,
which is capable of promoting the nuclease activity of Mre11-Rad50-Xrs2
(MRX). Additionally, phosphorylation of the C-terminal part of Sae2 is
prerequisite for interaction with Rad50, which is also essential to promote
MRX. These phosphorylation-dependent transitions mediate cell cycle and
DNA-damage-dependent control of DNA end resection capacity of MRX.
This prevents unscheduled DNA degradation by Mre11, aberrant
recombination and resulting genome instability
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ice and incubated for the indicated times at 30 °C. The complexes were mixed with
5 μl loading dye (50% glycerol, 0.1% bromophenol blue), loaded immediately on
native polyacrylamide gel (6% or 4%, as indicated, ratio of acrylamide:bisacryla-
mide 19:1), and separated by electrophoresis in TBE buffer (89 mM Tris base,
89 mM boric acid, 2 mM EDTA) on ice. Gels were dried on DE81 chromatography
paper (Whatman), exposed to a phosphor screen, and scanned using a Typhoon
Imager (GE Healthcare). Data were quantitated based on the disappearance of the
substrate band using the ImageQuant software. Error bars show standard error of
the mean. Two-tailed t test was used to calculate p values, where indicated. Dif-
ferences between two data populations with p values of >0.05 were not considered
signiﬁcant.
Size exclusion chromatography. The gel ﬁltration chromatography was carried
out using a Superose 6 10/300 GL column (GE Healthcare) on an ÄKTA prime
system (GE Healthcare). The separation buffer contained 50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 10% glycerol, and 0.5 mM β-mercaptoethanol. The recombinant
Sae2/pSae2 variant (~75 μg) was diluted into 200 μl of separation buffer, supple-
mented with 1 mM manganese chloride, and either treated with λ phosphatase
(4'800 U, New England Biolabs) or mock-treated (without λ phosphatase) for
90 min at 30 °C. The sample (200 μl) was then loaded onto the gel ﬁltration column
and separated at 0.2 ml/min at 4 °C. Owing to the low number of aromatic amino
acids in Sae2, the protein was monitored by absorbance at 215 nm.
Nuclease assays. Nuclease assays (15 μl volume) were carried out with
oligonucleotide-based substrates (1 nM molecules) in a buffer containing 25 mM
Tris-acetate, pH 7.5, 1 mM dithiothreitol, 5 mM magnesium acetate, 1 mM man-
ganese acetate, 1 mM ATP, 80 U/ml pyruvate kinase (Sigma), 1 mM phosphoe-
nolpyruvate, and 0.25 mg/ml bovine serum albumin (New England Biolabs).
Streptavidin (Sigma), 15 nM for the 50-bp substrate and 30 nM for the 70 bp
substrate, was added to the substrate containing reaction mixture and incubated for
5 min at room temperature. Recombinant proteins were then added on ice and
incubated for 30 min at 30 °C. Reactions were terminated with stop buffer (0.5 μl
10% [w/v] sodium dodecyl sulfate and 0.5 μl 0.5 M EDTA) and 0.5 μl proteinase K
(14–22 mg/ml, Roche), and incubated for 30 min at 37 °C. Terminated reaction
mixtures were mixed with an equal volume of loading dye (95% formamide,
20 mM EDTA, 1 mg/ml bromophenol blue) and separated by electrophoresis in
15% denaturing polyacrylamide gels (acrylamide:bisacrylamide, 19:1, Biorad) in
TBE buffer. The gels were ﬁxed for 30 min at room temperature in 40% methanol,
10% acetic acid, and 5% glycerol; dried on 3MM paper (Whatman); and exposed to
storage phosphor screen (GE Healthcare). The screens were scanned by a Typhoon
Imager (GE Healthcare). Images were quantitated using the ImageQuant software.
First, DNA cleavage in MRX-only lanes (without Sae2) was removed as a back-
ground from all lanes to score speciﬁcally for effects of Sae2. Subsequently, the
Sae2-dependent DNA cleavage was calculated as products/(substrate+ products)
in each lane. Error bars show standard error of the mean. Two-tailed t test was used
to calculate p values, where indicated. Differences between two data populations
with p values of >0.05 were not considered signiﬁcant.
Protein interaction assays. To analyze the binding of Sae2/pSae2 to MRX, MBP-
tagged Sae2 was expressed in Sf9 cells. Two separate cultures were made. The ﬁrst
cell pellet was obtained from cells upon treatment with phosphatase inhibitors as
described above, while for the second pellet, phosphatase inhibitors were omitted.
The respective cell extracts (with or without phosphatase inhibitors) were bound to
50 μl amylose resin (New England Biolabs) for 1 h at 4 °C as described in the
preparation of recombinant proteins section. The resin was then washed batchwise
5 times with 1 ml wash buffer (50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 80 mM
NaCl, 0.2% NP40). After the last wash, the resin with the sample prepared without
phosphatase inhibitors was incubated with 800 U of λ phosphatase (New England
Biolabs) in the recommended buffer for 15 min at 30 °C, centrifuged brieﬂy, and
the supernatant was removed, while the second sample was mock-treated (without
λ phosphatase). Both resins were then incubated with 5 μg recombinant MRX for
1 h at 4 °C and washed 4 times with 1 ml wash buffer as described above. Proteins
were eluted with 100 μl wash buffer containing 20 mM maltose. To cleave the MBP
tag, the eluates were incubated for 1 h at 4 °C with 2 μg of Prescission protease.
Protein complexes were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and detected with silver staining. The same procedure
was used to test the binding of Sae2 to 1 μg of recombinant Mre11; Avidin was
added to the eluates as a protein stabilizer (100 ng/μl, Sigma), and western blot with
anti-His tag antibody (MBL, D291–3, dilution 1:1000) was used for detection.
To analyze the binding of the C-terminal fragment of Sae2 to Rad50 and its
variants, the MBP-pSae2 ΔN169 was ﬁrst partially puriﬁed on amylose resin,
eluted, and cleaved with PreScission protease. The phosphorylated fragment was
then bound to NiNTA resin in 50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 80 mM
NaCl, 0.2% NP40, and 10 mM imidazole and washed 5 times with 1 ml of the same
buffer. Half of the resin was then incubated with λ phosphatase for 30 min at 30 °C,
while the other half was mock-treated. (The amount of λ phosphatase was
determined in a separate experiment by monitoring pSae2 ΔN169
dephosphorylation by its mobility in polyacrylamide gel). After a short spin and
removal of the supernatant, the resins were incubated with 1 μg of puriﬁed Rad50
(or its variants) for 1 h at 4 °C. Resins were washed 6 times with 1 ml buffer as
above and the protein complexes were eluted with the same buffer containing 300
mM imidazole. The eluates were supplemented with Avidin to stabilize the proteins
(Sigma, 100 ng/μl) and analyzed by Ponceau staining or western blotting (anti-
Rad50 antibody, Thermo Scientiﬁc, PA5–32176, dilution 1:1000). To perform the
experiment reciprocally, Rad50-FLAG was expressed in Sf9 cells and the cell lysate
was bound to anti-FLAG M2 afﬁnity gel (Sigma, A2220) for 1 h at 4 °C as described
in the preparation of recombinant protein section. The resin was washed 5 times
with 1 ml wash buffer (50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 150 mM NaCl,
0.2% NP40) and incubated for 1 h at 4 °C with 1 μg of either mock-treated or
dephosphorylated pSae2 ΔN169. The resin was then washed 6 times with 1 ml
wash buffer and the protein complexes were eluted with wash buffer supplemented
with 200 μg/ml 3X FLAG peptide (Sigma). Avidin was added to the ﬁnal eluate
(100 ng/μl) as a stabilizer, and the protein complexes were analyzed by Ponceau
staining and western blotting with anti-His tag antibody (MBL, D291–3, dilution
1:1000).
Transmission electron microscopy. Non-sized Sae2 and pSae2 samples were
diluted to 800 nM in EM buffer (20 mM HEPES, 130 mM NaCl, 2% glycerol, and
0.5 mM DTT, pH 7.55) and 4 μl were applied to carbon ﬁlm 300 mesh copper grids
(CF300-CU from Electron Microscopy Sciences, 215–412–8400) that were glow
discharged for 45 s with 25 mA using the Emitech K100X glow discharge system
under conditions that create a negatively charged grid surface. After incubation of
1 min on the grid, the excess sample was manually blotted with Whatman ﬁlter
paper, washed twice with EM buffer, and stained with two drops of 2% uranyl
acetate. Transmission electron micrographs were acquired with a FEI Morgagni
268 microscope at 100 kV using a CCD 1376 × 1032 pixel camera at a nominal
defocus of −6 μm (Fig. 1i, j) or with a FEI Tecnai F20 FEG microscope at 200 kV
using a Falcon II 4 K Direct Electron Detector operated in low-dose mode and a
nominal defocus of −2 μm (Supplementary Fig. 2b, c).
Atomic force microscopy. In all, 50 nM hyperphosphorylated pSae2 in 40 mM
Hepes pH 7, 5 mM MgCl2, 25 mM NaCl, 0.1 mM Tris(2-carboxyethyl)phosphine
was deposited on freshly cleaved mica (Ted Pella, Inc.) for <1 min and then rinsed
with 800 μl of molecular biology grade water. The mica surface was dried by
blotting and a nitrogen stream. Images were captured in air with a Nanoscope IIIa
(Digital Instruments) microscope in tapping mode using PointProbe®Plus-NCL
silicon probes (Nanosensors). Images were collected at a size of 1×1 μm2. Image
Metrics v 1.13 (in-house Erie lab) was used for image processing and particle
volume analysis. Standard image processing utilized plane subtraction and ﬂat-
tening. Statistical analyses were carried out using GraphPad Prism 7.0 (GraphPad
Software Inc.). The molecular weight of pSae2 was derived from a Gaussian dis-
tribution of volumes as determined by ImageMetrics and a published standard
curve31.
Mass spectrometry. Puriﬁed pSae2 was run on a SDS-PAGE gel, stained with
Coomassie blue, and excised from the gel. Gel pieces were reduced with 10 mM
Tris(2-carboxyethyl)phosphine, alkylated with 20 mM iodoacetamide, and cleaved
with 0.1 µg porcine sequencing grade trypsin (Promega) in 25 mM ammonium
bicarbonate, pH 8.0, at 37 °C for 16 h. The extracted peptides were analyzed by
capillary liquid chromatography tandem mass spectrometry with an EASY-nLC
1000 using the two-column set-up (Thermo Scientiﬁc). The peptides were loaded
in 0.1% formic acid, 2% acetonitrile in water onto a peptide trap (Acclaim PepMap
100, 75 μm×2 cm, C18, 3 μm, 100 Å) at a constant pressure of 600 bar. Peptides
were separated at a ﬂow rate of 200 nl/min with a linear gradient of 2–30% buffer B
in buffer A in 20 min, followed by a linear increase from 30% to 50% in 5 min,
50–80% in 2 min, and the column was ﬁnally washed for 14 min at 80% B (Buffer
A: 0.1% formic acid, buffer B: 0.1% formic acid in acetonitrile) on a 75 μm×15 cm
ES800 C18, 2 μm, 100 Å column mounted on a DPV ion source (New Objective)
connected to a Orbitrap Velos (Thermo Scientiﬁc). The data were acquired using
60,000 resolution for the peptide measurements in the Orbitrap and a top 5 method
with a CID fragmentation for each precursor and fragment measurement in the
LTQ. Mascot Distiller 2.5 and MASCOT 2.5 searching the yeast sub set of the
swissprot version 2015_01 DB was used to identify the phospho peptides. The
enzyme speciﬁcity was set to trypsin allowing for up to three incomplete cleavage
sites. Carbamidomethylation of cysteine (+57.0245) was set as a ﬁxed modiﬁcation,
phosphorylation of serine, threonine and tyrosine (+79.9663 Da) oxidation of
methionine (+15.9949 Da), and acetylation of protein N-termini (+42.0106 Da)
were set as variable modiﬁcations. Parent ion mass tolerance was set to 5 ppm and
fragment ion mass tolerance to 0.6 Da. The results were validated with the program
Scaffold Version 4.4 and ScaffoldPTM (Proteome Software). Peptide identiﬁcations
were accepted if they could be established at >50.0% probability as speciﬁed by the
Peptide Prophet algorithm45,46, and phosphorylation sites were accepted if they
had a >80% site probability as calculated with ScaffoldPTM.
Spo11-oligonucleotide formation assay. In vivo nuclease activity of the MRX-
Sae2 complex was assessed via the release of Spo11 from meiotic DSB ends14,34,38.
Brieﬂy, S. cerevisiae cells were pregrown in YPA medium for 14–16 h (containing
300 µg/ml hygromycin to maintain CEN-plasmids), then washed, and resuspended
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in 1% potassium acetate with nutritional supplements. At the indicated time points,
culture samples (10–20 ml) were harvested, lysed in the presence of 10% tri-
chloroacetic acid, and resulting precipitates were dissolved in 2% SDS, 0.5 M Tris-
HCl, pH 8.1, and 1 mM EDTA. Soluble material was diluted four-fold to a ﬁnal
concentration of 1% Triton, 0.5% SDS, 140 mM Tris pH 8.1, 150 mM NaCl, 1 mM
EDTA, and incubated with mixing for >4 h at 4 °C with anti-FLAG antibody
(#F1804, Sigma-Aldrich) and Protein-G-agarose (#05015979001 Roche/Sigma-
Aldrich). Immune complexes were collected by centrifugation, washed, equilibrated
in 1× New England Biolabs Terminal transferase buffer, and incubated with 10 U
terminal deoxynucleotidyl transferase (#EP0161 Fermentas/ThermoFisher) and
5 µCi alpha-32P dCTP (Perkin Elmer) for 1 h at 37 °C. Labeled Spo11-oligo com-
plexes were washed, denatured in loading buffer, resolved by 8% SDS-PAGE, and
detected via phosphorimaging using a Fuji FLA5100 scanner and ImageGauge
software. Where indicated, quantitation is shown below the lines as an average
(relative to wt) ± coefﬁcient of variation (standard deviation/mean) and the
number of independent measurements (n).
Yeast strains and plasmids. S. cerevisiae strains used are derivatives of the SK1
genetic background. sae2Δ::KanMX and tel1Δ::HphNT2 are partial gene deletions
generated via LiAc transformation and are functional knockouts38,47. The clb2-HA-
MEC1::KanMX construct places MEC1 under the control of the mitosis-speciﬁc
CLB2 promoter and was generated via PCR-mediated transformation48. The cen-
tromeric vectors were generated by cloning the SAE2 open reading frame including
500 bp upstream and downstream into a derivative of pRS416 in which the
HphNT2 marker was cloned at the MCS. The HA3 in-frame tag was cloned into an
NheI site generated at the C-terminus of SAE2 by site-directed mutagenesis.
Individual point mutations in the SAE2 ORF were introduced via site-directed
mutagenesis using standard methods. Inducible SAE2 constructs were generated by
cloning 502 bp of the SAE2 5’ untranslated region (UTR) and 1192 bp (or truncated
fragments) of the SAE2 ORF plus 3’ UTR into plasmid pYM_N2349 ﬂanking the
GAL1 promoter. Point mutations were introduced by site-directed mutagenesis.
Fragments were liberated by restriction digestion and transformed into host strains
harboring the Gal4-ER fusion construct inserted at the URA3 locus48, thereby
modifying the natural SAE2 locus. The base SK1 haploid genotype is: ho::LYS2,
lys2, arg4-nsp, leu2::hisG, his4X::LEU2, nuc1::LEU2, SPO11-FLAG3His3::KanMX. A
complete list of all strains, plasmids, mutagenesis primers, and construction details
is available on request.
Data availability
All relevant data are available from the corresponding authors upon reasonable request.
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